Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- NA
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
- Status
- UNKNOWN
- Phase
- NA
Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2